Diagnostic and Biotech

Europe Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

  • THE3206951
  • 149 Pages
  • February 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Europe human microbiome market is expected to reach US$ 346.67 Mn in 2025 from US$ 72.34 in 2017. The market is estimated to grow with a CAGR of 22.2% from 2018-2025. The growth of the market is driven by the factors such alarming rise in non-communicable diseases (NCDS), rising efforts in the development of human microbiome based therapies and developments in genomics and sequencing techniques. Whereas, rigorous government regulations for advanced therapies and limited understanding is likely to have a negative impact on the growth of the market in the coming years.

Fecal microbiota transplantation (FMT) has developed as an effective treatment for C. difficile infection (CDI) refractory towards antibiotic therapy. The microbiota have important roles in the function of gastrointestinal tract and other aspects of human physiology, there is also growing interest in studying FMT for other clinical indications. The US Food and Drug Administration (FDA) has classified human stool as a biological agent and determined that its use in fecal microbiota transplantation (FMT) therapy and other research are regulated for the insurance of patient safety. With the use of FMT in the treatment of recurrent Clostridium difficile infection (RCDI), an investigational new drug (IND) permit is not required, but is strongly encouraged and may ultimately be required.

Some of the available data suggests that the use of fecal microbiota for the restoration of intestinal flora may be an effective therapy in the management of refractory C. difficile infection. According to the study, "Fecal Microbiota Transplant in Patients with Recurrent Clostridium Difficile Infection" published in Deutscher Ärzteverlag GmbH in 2016 concluded that FMT is a safe and effective treatment option for rCDI but FMT is available only in few centers in Germany. Thus clinical effectiveness of this therapy poses opportunities for the human microbiome treatment to grow in the European region.

Germany is anticipated to lead the adoptions of Human microbiome across the Europe region through the forecast period. Human microbiome is an emerging field in the country and the developments are being conducted widely in the country. The genome-wide association analysis study carried out in Germany was published in 2016. The study identifies variation in vitamin D receptor and other host factors influence the gut microbiota.

In addition, Germany invests considerably for innovation and development of new technologies and procedures. For instance, in April 2017, the German Science Council, has approved 53 million euros in funding for an Institute of Microbiota and Cancer Research in Tübingen. Thus, considering and analyzing the above mentioned factors, the human microbiome market is likely to grow with a significant growth rate in the coming future.

Exhibit: Rest Of Europe Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)

EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION

By Product

Probiotics

Foods

Prebiotics

Medical Foods

Diagnostic Device

Drugs

Supplements

EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION

By Disease

Obesity

Diabetes

Autoimmune Disorders

Cancer

Mental Disorders

Others

EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION

By Application

Therapeutics

Diagnostics

By Country

U.S.

Canada

Mexico

Companies Mentioned

Enterome

MicroBiome Therapeutics, LLC

Rebiotix Inc.

Yakult Honsha Co., Ltd.

Osel Inc.

Vedanta Biosciences, Inc.

Metabiomics Corporate

Synthetic Biologics, Inc.

DuPont

BiomX Ltd.

TABLE OF CONTENTS

PART 1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. EUROPE HUMAN MICROBIOME MARKET - KEY TAKEAWAYS

PART 3. EUROPE HUMAN MICROBIOME MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 Europe Human Microbiome Market - By Product

3.2.2 Europe Human Microbiome Market - By Disease

3.2.3 Europe Human Microbiome Market - By Application

3.2.4 Europe Human Microbiome Market - By Country

3.3 PEST ANALYSIS

3.3.1 Europe - PEST Analysis

PART 4. EUROPE HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Alarming Rise In Non-Communicable Diseases (NCDs)

4.1.2 Rising Efforts in the Development of Human Microbiome based Therapies

4.1.3 Developments in Genomics and Sequencing techniques

4.2 KEY MARKET RESTRAINTS

4.2.1 Rigorous Government Regulations for Advanced Therapies

4.2.2 Limited Understanding Restricts the Growth of Market

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Increasing Acceptance of Faecal Microbiota Transplantation

4.4 FUTURE TRENDS

4.4.1 Recent Advances in Human Microbiome Drug Discovery

4.5 IMPACT ANALYSIS

PART 5. HUMAN MICROBIOME MARKET - EUROPE ANALYSIS

5.1 EUROPE HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS

5.3 MARKET POSITIONING

5.4 PERFORMANCE OF KEY PLAYERS

Enterome

Yakult Honsha Co., Ltd.

5.5 EXPERT OPINIONS

PART 6. EUROPE HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT

6.1 OVERVIEW

6.2 EUROPE HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

6.3 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

6.4 FOODS MARKET

6.4.1 Overview

6.4.2 Europe Foods Market Revenue and Forecasts to 2025 (US$ Mn)

6.5 MEDICAL FOOD MARKET

6.5.1 Overview

6.5.2 Europe Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)

6.6 PROBIOTICS MARKET

6.6.1 Overview

6.6.2 Europe Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.7 PREBIOTICS MARKET

6.7.1 Overview

6.7.2 Europe Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.8 DRUGS MARKET

6.8.1 Overview

6.8.2 Europe Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

6.9 DIAGNOSTIC DEVICES MARKET

6.9.1 Overview

6.9.2 Europe Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)

6.10 SUPPLEMENTS MARKET

6.10.1 Overview

6.10.2 Europe Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. EUROPE HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE

7.1 OVERVIEW

7.2 EUROPE HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)

7.3 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

7.4 DIABETES MARKET

7.4.1 Overview

7.4.2 Europe Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)

7.5 CANCER MARKET

7.5.1 Overview

7.5.2 Europe Cancer Market Revenue and Forecasts to 2025 (US$ Mn)

7.6 AUTOIMMUNE DISORDERS MARKET

7.6.1 Overview

7.6.2 Europe Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.7 OBESITY MARKET

7.7.1 Overview

7.7.2 Europe Obesity Market Revenue and Forecasts to 2025 (US$ Mn)

7.8 MENTAL DISORDERS MARKET

7.8.1 Overview

7.8.2 Europe Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.9 OTHERS MARKET

7.9.1 Overview

7.9.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. EUROPE HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION

8.1 OVERVIEW

8.2 EUROPE HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)

8.3 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

8.4 DIAGNOSTICS MARKET

8.4.1 Overview

8.4.2 Europe Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)

8.5 THERAPEUTICS MARKET

8.5.1 Overview

8.5.2 Europe Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025

9.1 OVERVIEW

9.2 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.3 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

9.4 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

9.5 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

9.6 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

9.7 UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.7.1 UK Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.7.2 UK Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.7.3 UK Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.7.4 UK Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.8 GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.8.1 Germany Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.8.2 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.8.3 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.8.4 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.9 FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.9.1 France Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.9.2 France Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.9.3 France Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.9.4 France Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE

10.1 OVERVIEW

10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

10.3 ORGANIC GROWTH STRATEGIES

10.3.1 Overview

10.3.2 Product Launch & Approvals

10.3.3 Expansion

10.3.4 Patent and license

10.4 INORGANIC GROWTH STRATEGIES

10.4.1 Overview

10.4.2 Acquisitions

10.4.3 Partnerships, Collaborations & Agreements

10.4.4 Joint Ventures

PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES

11.1 ENTEROME

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Financial Overview

11.1.4 Product Portfolio

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 MICROBIOME THERAPEUTICS, LLC

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Financial Information

11.2.4 Product Portfolio

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 REBIOTIX INC.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Financial Overview

11.3.4 Product Portfolio

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 YAKULT HONSHA CO., LTD.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Overview

11.4.4 Product Portfolio

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 OSEL INC.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Financial Overview

11.5.4 Product Portfolio

11.5.5 Swot Analysis

11.5.6 Key Developments

11.6 VEDANTA BIOSCIENCES, INC.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Financial Information

11.6.4 Product Portfolio

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 METABIOMICS CORPORATE

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Financial Overview

11.7.4 Product Portfolio

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 SYNTHETIC BIOLOGICS, INC.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Financial Information

11.8.4 Product Portfolio

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 DUPONT

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Financial Overview

11.9.4 Product Portfolio

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 BIOMX

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Information

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

PART 12. APPENDIX

12.1 ABOUT THE INSIGHT PARTNERS

12.2 GLOSSARY OF TERMS

12.3 METHODOLOGY

12.3.1 Coverage

12.3.2 Secondary Research

12.3.3 Primary Research

LIST OF TABLES

TABLE 1. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 2. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 3. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 4. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 5. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 6. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 7. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 8. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 9. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 10. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 11. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 12. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 13. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 14. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 15. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET

TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET

TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET

TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET

TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

LIST OF FIGURES

FIGURE 1. UK HUMAN MICROBIOME MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2025

FIGURE 2. EUROPE HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017

FIGURE 3. EUROPE HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017

FIGURE 4. EUROPE HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017

FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION

FIGURE 6. EUROPE PEST ANALYSIS

FIGURE 7. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 8. EUROPE HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025

FIGURE 9. EUROPE HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

FIGURE 10. EUROPE FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 11. EUROPE MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 12. EUROPE PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 13. EUROPE PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 14. EUROPE DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 15. EUROPE DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 16. EUROPE SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 17. EUROPE HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)

FIGURE 18. EUROPE DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 19. EUROPE CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 20. EUROPE AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 21. EUROPE OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 22. EUROPE MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 23. EUROPE OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 24. EUROPE HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)

FIGURE 25. EUROPE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 26. EUROPE THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 27. EUROPE HUMAN MICROBIOME MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)

FIGURE 28. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 29. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

FIGURE 30. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 31. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 32. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 33. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 34. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 35. INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370